TY - JOUR T1 - Evaluation of the Antiproliferative Effect of Safranal in C-4 I Cervical Cancer Cell Line TT - Safranal'ın Servikal Kanseri C-4 I Hücre Hattı Üzerindeki Antiproliferatif Etkisinin Değerlendirilmesi AU - Athoumanı Alı, Souandaou AU - Özcan, Fatma Gül AU - Karabulut-bulan, Omur PY - 2023 DA - October DO - 10.59312/ebshealth.1367528 JF - Doğu Karadeniz Sağlık Bilimleri Dergisi JO - EBSHealth PB - Giresun Üniversitesi WT - DergiPark SN - 2822-6445 SP - 117 EP - 128 VL - 2 IS - Kongre Özel Sayısı LA - en AB - Aim: Safranal is a bioactive compound responsible for the aroma propriety of Crocus sativus. Many studies have shown the antioxidant activity of safranal besides some pharmacological properties, including its anti-inflammatory effect. Our study aimed on identifying the cytotoxic effects of safranal on the C-4 I cell line of cervical cancer. Methods: The cytotoxic effect of safranal on the C-4 I cell line was determined after incubating the cells for certain durations (2 to 72 hours) and concentrations (25 to 800 µM). After incubation, cell viability and anti-proliferation effect of safranal were determined respectively by Mitochondrial Dehydrogenase and Lactate dehydrogenase enzymes activities assays. Additionally, morphological changes occurring during incubation in cells were examined with inverted and optical microscope using Giemsa staining. Results: According to the results, compared to Control group, the % viability of treated cells was decreased depending on concentration and the incubation time, and safranal significantly inhibited the growth of C-4 I cells (p KW - C-4 I KW - Safranal KW - Cervical cancer KW - Cytotoxicity KW - Antiproliferative N2 - Amaç: Safranal, Crocus sativus’un aroma özelliğinden sorumlu bioaktif bir bileşendir. Safranalın antiinflamatuar etkisi dahil olmak üzere farmakolojik özelliklerinin yanı sıra antioksidan aktivitesi birçok çalışmada gösterilmiştir. Çalışmamızda, safranalın serviks karsınoma kökenli C-4 I hücre hattı üzerindeki sitotoksik etkilerini tespit etmek amaçlanmıştır. Yöntem: Safranalın C-4 I hücre hattı üzerindeki sitotoksik etkisini belirlemek için hücreler belirli sürelerde (2-72 saat) ve konsantrasyonlarda (25-800μM) inkübe edildi. İnkübasyon süresi bitiminde hücrelerin viabilitesi ve safranal antiproliferatif etkisi sırasıyla Mitokondriyal Dehidrojenaz ve Laktat dehidrojenaz enzimlerinin aktiviteleri ile belirlendi. Bununla birlikte, inkübasyon süresince meydana gelen morfolojik değişiklikler Faz kontrast ve ışık mikroskopları aracılığıyla Giemsa boyama kullanılarak gözlemlendi. Bulgular: elde edilen sonuçlara göre, safranal ile tedavi edilen hücreler kontrol grubu ile karşılaştırıldığında hücrelerin canlılık yüzdesi doza ve inkübasyon süresine bağlı olarak azaldı ve safranal C-4 I hücrelerinin çoğalmasını anlamlı bir şekilde inhibe etti (p CR - Bakshi, H. A., Quinn, G. A., Nasef, M. M., Mishra, V., Aljabali, A. A. A., El-Tanani, M., Serrano-Aroca, Á., Webba Da Silva, M., McCarron, P. A., & Tambuwala, M. M. (2022). Crocin Inhibits Angiogenesis and Metastasis in Colon Cancer via TNF-α/NF-kB/VEGF Pathways. Cells, 11(9), 1502. https://doi.org/10.3390/cells11091502. CR - Burak, A. K. Ç. A., & Güven, L. (2023). Kanser Tedavisinde Kullanılan Tıbbi Bitkiler. Sağlık Bilimlerinde Öncü Ve Çağdaş Çalışmalar, 641-679. https://scholar.google.com/citations?view_op=view_citation&hl=tr&user=pHHgdH8AAAAJ&citation_for_view=pHHgdH8AAAAJ:MXK_kJrjxJIC CR - Cerdá-Bernad, D., Valero-Cases, E., Pastor, J. J., & Frutos, M. J. (2022). Saffron bioactives crocin, crocetin and safranal: effect on oxidative stress and mechanisms of action. Critical reviews in food science and nutrition, 62(12), 3232–3249. https://doi.org/10.1080/10408398.2020.1864279. CR - Chaiboonchoe, A., Khraiwesh, B., Murali, C., Baig, B., Tarazi, H., Alzahmi, A., Nelson, D. R., Greish, Y. E., Ramadan, W., & Amin, A. (2018). Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells. Scientific Reports, 8(1), 1-15. https://doi.org/10.1038/s41598-018-34855-0 CR - Cheriyamundath, S., Choudhary, S., & Lopus, M. (2017). Safranal Inhibits HeLa Cell Viability by Perturbing the Reassembly Potential of Microtubules. Phytotherapy Research, 32(1), 170-173. https://doi.org/10.1002/ptr.5938 CR - Chermahini, S.H., Majid, F.A.A., Sarmidi, M.R., Taghizadeh, E., Salehnezhad, S., 2010, Impact of saffron as an anti-cancer and anti-tumor herb, African Journal of Pharmacy and Pharmacology, 4(11), 834-840. https://doi.org/10.5897/AJPP.9000175 CR - Erkekoğlu, P., & Baydar, T., (2021). Current in vitro cytotoxicity tests Güncel In Vitro Sitotoksisite Testleri. Hacettepe University Journal of the Faculty of Pharmacy , vol.41, no.1, 45-63. CR - Esmaeilzadeh, D., Moodi Ghalibaf, A., Shariati Rad, M., Rezaee, R., Razavi, B. M., & Hosseinzadeh, H. (2023). Pharmacological effects of Safranal: An updated review. Iranian Journal of Basic Medical Sciences, 26(10), 1131-1143. doi: 10.22038/ijbms.2023.69824.15197 CR - Gavas, S., Quazi, S., & Karpiński, T. M. (2021). Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters, 16. https://doi.org/10.1186/s11671-021-03628-6 CR - González Martín A. (2007). Molecular biology of cervical cancer. Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 9(6), 347–354. https://doi.org/10.1007/s12094-007-0066-8 CR - Greenwell, M., & Rahman, S. M. (2015). Medicinal Plants: Their Use in Anticancer Treatment. International Journal of Pharmaceutical Sciences and Research, 6(10), 4103. https://doi.org/10.13040/IJPSR.0975-8232.6(10).4103-12 CR - Hatziagapiou, K., Nikola, O., Marka, S., Koniari, E., Kakouri, E., Zografaki, M., Mavrikou, S. S., Kanakis, C., Flemetakis, E., Chrousos, G. P., Kintzios, S., Lambrou, G. I., & Tarantilis, P. A. (2022). An In Vitro Study of Saffron Carotenoids: The Effect of Crocin Extracts and Dimethylcrocetin on Cancer Cell Lines. Antioxidants, 11(6), 1074. https://doi.org/10.3390/antiox11061074 CR - Hosseinzadeh, H., & Sadeghnia, H. R. (2005). Safranal, a constituent of Crocus sativus (saffron), attenuated cerebral ischemia induced oxidative damage in rat hippocampus. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 8(3), 394–399. PubMed. https://pubmed.ncbi.nlm.nih.gov/16401389/ CR - Jabini, R., Ehtesham-Gharaee, M., Dalirsani, Z., Mosaffa, F., Delavarian, Z., & Behravan, J. (2017). Evaluation of the Cytotoxic Activity of Crocin and Safranal, Constituents of Saffron, in Oral Squamous Cell Carcinoma (KB Cell Line). Nutrition and cancer, 69(6), 911–919. https://doi.org/10.1080/01635581.2017.1339816 CR - Liontos, M., Kyriazoglou, A., Dimitriadis, I., Dimopoulos, M. A., & Bamias, A. (2019). Systemic therapy in cervical cancer: 30 years in review. Critical reviews in oncology/hematology, 137, 9–17. https://doi.org/10.1016/j.critrevonc.2019.02.009 CR - Maeda, A., Kai, K., Ishii, M., Ishii, T., & Akagawa, M. (2014). Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice. Molecular Nutrition & Food Research, 58(6), 1177-1189. https://doi.org/10.1002/mnfr.201300675 CR - Malaekeh-Nikouei, B., Mousavi, S. H., Shahsavand, S., Mehri, S., Nassirli, H., & Moallem, S. A. (2013). Assessment of cytotoxic properties of safranal and nanoliposomal safranal in various cancer cell lines. Phytotherapy research : PTR, 27(12), 1868–1873. https://doi.org/10.1002/ptr.4945 CR - Milajerdi, A., Djafarian, K., & Hosseini, B. (2016). The toxicity of saffron (Crocus sativus L.) and its constituents against normal and cancer cells. Journal of Nutrition & Intermediary Metabolism, 3, 23-32. https://doi.org/10.1016/j.jnim.2015.12.332 CR - Mollazadeh, H., Emami, S. A., & Hosseinzadeh, H. (2015). Razi’s Al-Hawi and saffron (Crocus sativus): A review. Iranian Journal of Basic Medical Sciences, 18(12), 1153-1166. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744354/ CR - Moratalla-López, N., Bagur, M. J., Lorenzo, C., Martínez-Navarro, M. E., Salinas, M. R., & Alonso, G. L. (2019). Bioactivity and Bioavailability of the Major Metabolites of Crocus sativus L. Flower. Molecules, 24(15). https://doi.org/10.3390/molecules24152827 CR - Nanda, S., & Madan, K. (2021). The role of Safranal and saffron stigma extracts in oxidative stress, diseases and photoaging: A systematic review. Heliyon, 7(2), e06117. https://doi.org/10.1016/j.heliyon.2021.e06117 CR - Ozcan, G., Dagdeviren Ozsoylemez, O., Akman, G., Khalilia, W., Tezel Yetiz, B., Karagoz, A., Melikoglu, G., Anil, S., Kultur, S., & Sutlupinar, N. (2016). Screening for antitumor activity of various plant extracts on HeLa and C 4-I cell lines. Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 21(6), 1552–1560. CR - Ozsoylemez, O. D., & Ozcan, G. (2018). The Antiproliferative Activity of Colchicum umbrosum Plant Extract and Paclitaxel on C-4 I and Vero Cells. European Journal of Biology, 77(2), 81-88. https://doi.org/10.26659/EurJBiol.2018.0016 CR - Rezaee, R., & Hosseinzadeh, H. (2013). Safranal: From an Aromatic Natural Product to a Rewarding Pharmacological Agent. Iranian Journal of Basic Medical Sciences, 16(1), 12-26. doi: 10.22038/ijbms.2013.244 CR - Samarghandian, S., & Shabestari, M. M. (2013). DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line. Indian Journal of Urology : IJU : Journal of the Urological Society of India, 29(3), 177-183. https://doi.org/10.4103/0970-1591.117278 CR - Samarghandian, S., & Shabestari, M. M. (2013). DNA fragmentation and apoptosis induced by safranal in human prostate cancer cell line. Indian Journal of Urology : IJU : Journal of the Urological Society of India, 29(3), 177-183. https://doi.org/10.4103/0970-1591.117278 CR - Samarghandian, S., Samini, F., Azimi-Nezhad, M., & Farkhondeh, T. (2017). Anti-oxidative effects of safranal on immobilization-induced oxidative damage in rat brain. Neuroscience letters, 659, 26–32. https://doi.org/10.1016/j.neulet.2017.08.065 CR - Samarghandian, S., Shoshtari, M. E., Sargolzaei, J., Hossinimoghadam, H., & Farahzad, J. A. (2014). Anti-tumor activity of safranal against neuroblastoma cells. Pharmacognosy Magazine, 10(Suppl 2), S419. https://doi.org/10.4103/0973-1296.133296 CR - Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: a cancer journal for clinicians, 70(1), 7–30. https://doi.org/10.3322/caac.21590 CR - Tokur, O. & Aksoy, A. (2017). In Vitro Sitotoksisite Testleri . Harran Üniversitesi Veteriner Fakültesi Dergisi , 6 (1) , 112-118 . https://doi.org/10.31196/huvfd.325794 CR - Toledo-Ibelles, P., & Mas-Oliva, J. (2018). Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?. Current atherosclerosis reports, 20(7), 36. https://doi.org/10.1007/s11883-018-0737-7 CR - Xu, Q., Yu, J., Jia, G., Li, Z., & Xiong, H. (2022). Crocin attenuates NF-κB-mediated inflammation and proliferation in breast cancer cells by down-regulating PRKCQ. Cytokine, 154, 155888. https://doi.org/10.1016/j.cyto.2022.155888 CR - Zarrineh, M., Ashrafian, S., Jensen, P., Nawrocki, A., Ansari, A. M., Rezadoost, H., Ghassempour, A., & Larsen, M. R. (2022). Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines. Journal of Proteomics, 259, 104539. https://doi.org/10.1016/j.jprot.2022.104539 UR - https://doi.org/10.59312/ebshealth.1367528 L1 - https://dergipark.org.tr/tr/download/article-file/3438681 ER -